Press Releases Windtree Therapeutics, Inc.

Equities

WINT

US97382D5014

Market Closed - Nasdaq Other stock markets 04:30:00 2024-05-22 pm EDT			5-day change	1st Jan Change
4.105 ^USD	-3.41%		-10.78%	-68.28%

Apr. 16	Windtree Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Apr. 11	North American Morning Briefing : Stock Futures -2-	DJ

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Windtree Therapeutics Regains Compliance with Nasdaq	May. 07	AQ
Windtree Therapeutics : April'24 Corporate Presentation	Apr. 24	PU
Windtree Therapeutics Announces Reverse Stock Split	Apr. 18	AQ
Windtree Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Key Business Updates	Apr. 17	AQ
Windtree Acquires Early-Stage, Novel Oncology Platform and Completes $1.5 Million Convertible Note Bridge Financing	Apr. 08	AQ
Windtree Renews Agreement with Chang Gung University for Scientific Collaboration to Further SERCA2a Research	Feb. 01	AQ
Windtree Therapeutics Announces Engagement of Strategic Advisor to Support Assessment of Strategic Alternatives	Jan. 31	AQ
Windtree Eliminates $15 Million Contingent Liability to Deerfield Management Company	Jan. 25	AQ
WINDTREE THERAPEUTICS ANNOUNCES LICENSE AGREEMENT WITH LEE'S PHARMACEUTICALS TO DEVELOP AND COMMERCIALIZE ISTAROXIME, DUAL MECHANISM SERCA2A ACTIVATORS AND ROSTAFUROXIN FOR GREATER CHINA, ASIA PACIFIC REGION	Jan. 18	AQ
Windtree Therapeutics Announces License Agreement with Lee’s Pharmaceuticals to Develop and Commercialize Istaroxime, Dual Mechanism SERCA2a Activators and Rostafuroxin for Greater China / Asia Pacific Region	Jan. 17	AQ
WINDTREE THERAPEUTICS ANNOUNCES REDUCTION IN ARRYTHMIAS IN A NEW STUDY WITH ISTAROXIME AND A PURE SERCA2A ACTIVATOR	Jan. 03	AQ
Windtree Therapeutics Announces Reduction In Arrythmias In A New Study With Istaroxime And A Pure SERCA2a Activator	Jan. 02	AQ
Windtree Therapeutics Announces the Start of Patient Dosing In Phase 2 SEISMiC Extension Study of Istaroxime in Early Cardiogenic Shock	Dec. 18	AQ
Windtree Therapeutics Announces Issuance of New Pure SERCA2a Activator Patent	Nov. 16	AQ
Windtree Therapeutics Reports Third Quarter 2023 Financial Results and Provides Key Business Updates	Nov. 09	AQ
Windtree to Present at the Sidoti Micro Cap Conference on November 16th	Nov. 08	AQ
Windtree to Present at the ThinkEquity Conference on October 19th in New York City	23-10-12	AQ
Windtree to Participate in the Lytham Partners Fall 2023 Investor Conference on October 17th	23-10-10	AQ
Windtree to Present at the Dawson James Small Cap Growth Conference on October 12th	23-10-03	AQ
Windtree Therapeutics : September'23 Corporate Presentation	23-09-14	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Windtree Therapeutics, Inc.

Equities

WINT

US97382D5014

Press Releases

Filters